We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$490M
AUM Growth
+$17M
Cap. Flow
-$28.2M
Cap. Flow %
-5.75%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$13.5M
2
STAA icon
STAAR Surgical
STAA
+$5.13M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 60.08%
2 Consumer Staples 35.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$173M 35.35%
9,594,816
– –
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$160M 32.73%
1,619,968
-11,000
-0.7% -$1.01M
STAA icon
3
STAAR Surgical
STAA
$1.21B
$67.6M 13.79%
7,417,582
+530,487
+8% +$5.13M
LCTX icon
4
Lineage Cell Therapeutics
LCTX
$269M
$66.5M 13.57%
22,095,035
+5,006,257
+29% +$13.5M
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$22.4M 4.57%
817,029
– –
MNST icon
6
PUT
Monster Beverage
MNST
$94.3B
– –
-3,000,000
Closed -$45.8M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Broadwood Capital held 6 positions worth $490M, up 3.6% from $473M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $28.2M in Q4 2014, closing 1 position and reducing 1 holding. Its largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Consumer Staples.

Against the trend, Broadwood Capital added an estimated $13.5M to Lineage Cell Therapeutics.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q4 2014, an estimated $13.5M increase.
  • Broadwood Capital's biggest Q4 2014 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $1.01M.
  • Broadwood Capital's ten largest holdings make up 100% of its $490M portfolio in Q4 2014.
  • Broadwood Capital opened 0 new positions and closed 1 in Q4 2014.
  • Broadwood Capital's portfolio value rose 3.6% quarter-over-quarter to $490M.

Based on Broadwood Capital's 13F filing for Q4 2014, filed 17 Feb 2015.